Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Background: There is no established management algorithm for portal vein thrombosis (PVT) in cirrhotic patients. The aim of our study was to prospectively evaluate anticoagulation and transjugular intrahepatic portosystemic shunt (TIPS) to treat PVT. Methods: Cirrhotics with non‐malignant PVT were included. Low weight molecular heparin anticoagulation was considered in all; TIPS was indicated if thrombosis progressed or anticoagulation was contraindicated. Patients who were not anticoagulated nor received TIPS served as controls. Results: Fifty‐six patients (of whom 21 controls) were included. PVT was occlusive in 11/35, with extension to the superior mesenteric or splenic vein in 13/35. In the study group 33 patients were anticoagulated, with a recanalization rate of 36% (12/33) compared with 1/21 among controls. A time interval between appearance of thrombosis and anticoagulation < 6 months predicted chance of repermeation. Thrombus progression occurred in 15/21 non anticoagulated patients and in 5/33 anticoagulated patients (P < 0.001). TIPS was placed in six patients. There were five variceal bleedings and two intestinal venous ischaemia episodes in the control group, compared with one variceal bleeding episode in the study group. Conclusions: In cirrhotics with PVT, a treatment algorithm using anticoagulation and TIPS achieves a good chance of complete repermeation, reduces portal hypertensive complications, and decreases the rate of thrombosis progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute Portal Vein Thrombosis Unrelated to Cirrhosis: A Prospective Multicenter Follow-Up Study
Plessier, A., Darwish-Murad, S., Hernandez-Guerra, M., Consigny, Y., Fabris, F., Trebicka, J., Heller, J., Morard, I., Lasser, L., Langlet, P., et al. (2010) · Hepatology · doi:10.1002/hep.23259 · Cited by 597
Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis
Amitrano, L., Anna Guardascione, M., Brancaccio, V., Margaglione, M., Manguso, F., Iannaccone, L., Grandone, E., & Balzano, A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.01.001 · Cited by 582
Francoz, C., Belghiti, J., Vilgrain, V, Sommacale, D., Paradis, V, Condat, B., Denninger, M. H., Sauvanet, A., Valla, D., & Durand, F. (2005) · Gut · doi:10.1136/gut.2004.042796 · Cited by 536
Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy
Condat, B., Pessione, F., Hillaire, S., Denninger, M.-H., Guillin, M.-C., Poliquin, M., Hadengue, A., Erlinger, S., & Valla, D. (2001) · Gastroenterology · doi:10.1053/gast.2001.21209 · Cited by 516
Condat, B., Pessione, F., Denninger, M. H., Hillaire, S., & Valla, D. (2000) · Hepatology · doi:10.1053/jhep.2000.16597 · Cited by 492
Portal vein thrombosis in adults: pathophysiology, pathogenesis and management
Valla, D.-C., & Condat, B. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80259-7 · Cited by 377
Amitrano, L., Guardascione, M. A., Menchise, A., Martino, R., Scaglione, M., Giovine, S., Romano, L., & Balzano, A. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181b3ab44 · Cited by 293
Systematic review: portal vein thrombosis in cirrhosis
TSOCHATZIS, E. A., SENZOLO, M., GERMANI, G., GATT, A., & BURROUGHS, A. K. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04182.x · Cited by 285
Self-citationThe Incidence of Portal Vein Thrombosis At Liver Transplantation
Nonami, T., Yokoyama, I., Iwatsuki, S., & Starzl, T. E. (1992) · Hepatology · doi:10.1002/hep.1840160515 · Cited by 273
Landefeld, C. S., Cook, E. F., Flatley, M., Weisberg, M., & Goldman, L. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90004-0 · Cited by 264
Cited by
EASL Clinical Practice Guidelines: Vascular diseases of the liver
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.040 · Cited by 808
Northup, P. G., Garcia‐Pagan, J. C., Garcia‐Tsao, G., Intagliata, N. M., Superina, R. A., Roberts, L. N., Lisman, T., & Valla, D. C. (2021) · Hepatology · doi:10.1002/hep.31646 · Cited by 667
Loffredo, L., Pastori, D., Farcomeni, A., & Violi, F. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.042 · Cited by 410
Intagliata, N. M., Caldwell, S. H., & Tripodi, A. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.265 · Cited by 364
Villa, E., Bianchini, M., Blasi, A., Denys, A., Giannini, E. G., de Gottardi, A., Lisman, T., de Raucourt, E., Ripoll, C., & Rautou, P.-E. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.09.003 · Cited by 318
Quality Improvement Guidelines for Transjugular Intrahepatic Portosystemic Shunts
Dariushnia, S. R., Haskal, Z. J., Midia, M., Martin, L. G., Walker, T. G., Kalva, S. P., Clark, T. W. I., Ganguli, S., Krishnamurthy, V., Saiter, C. K., et al. (2016) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2015.09.018 · Cited by 271
Coagulation in liver disease: A guide for the clinician
Northup, P. G., & Caldwell, S. H. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.026 · Cited by 268
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis
Candeloro, M., Valeriani, E., Monreal, M., Ageno, W., Riva, N., Lopez-Reyes, R., Peris, M. L., Beyer Westendorf, J., Schulman, S., Rosa, V., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007961 · Cited by 36
“Four studies were international prospective multicenter registries,(3,4,26,27) and 1 study included patients from a single center.(21) Sample sizes ranged between 57 and 975 patients.”
BackgroundSelf-citation
Metadata
- Authors
- Senzolo, M., M. Sartori, T., Rossetto, V., Burra, P., Cillo, U., Boccagni, P., Gasparini, D., Miotto, D., Simioni, P., Tsochatzis, E., & A. Burroughs, K.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2012-03-21
- Volume
- 32
- Issue
- 6
- Pages
- 919-927
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W2172060670
- Cited by
- 327
- References
- 18
- FWCI
- 15.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.